Healthcare provider profile · identity verified

Daniel B Jankins, MD

Internal Medicine · MILWAUKEE, WI · NPI 1093756272

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	618	163
Amlodipine Besylate	Amlodipine Besylate	513	126
Losartan Potassium	Losartan Potassium	337	83
Levothyroxine Sodium	Levothyroxine Sodium	290	63
Lisinopril	Lisinopril	245	66
Metoprolol Succinate	Metoprolol Succinate	221	45
Pantoprazole Sodium	Pantoprazole Sodium	209	58
Rosuvastatin Calcium	Rosuvastatin Calcium	201	52
Eliquis	Apixaban	184	37
Tamsulosin Hcl	Tamsulosin Hcl	166	43
Sertraline Hcl	Sertraline Hcl	162	26
Gabapentin	Gabapentin	149	37
Omeprazole	Omeprazole	119	30
Simvastatin	Simvastatin	111	31
Allopurinol	Allopurinol	105	26
Hydrochlorothiazide	Hydrochlorothiazide	101	26
Albuterol Sulfate Hfa	Albuterol Sulfate	97	34
Tramadol Hcl	Tramadol Hcl	97	18
Metformin Hcl	Metformin Hcl	82	22
Ozempic	Semaglutide	73	12
Potassium Chloride	Potassium Chloride	73	21
Furosemide	Furosemide	69	27
Clonazepam	Clonazepam	68	11
Zolpidem Tartrate	Zolpidem Tartrate	68	14
Metformin Hcl Er	Metformin Hcl	65	23
Trazodone Hcl	Trazodone Hcl	62	18
Escitalopram Oxalate	Escitalopram Oxalate	60	19
Alendronate Sodium	Alendronate Sodium	59	13
Jardiance	Empagliflozin	57	12
Carvedilol	Carvedilol	53	13
Famotidine	Famotidine	53	17
Mounjaro	Tirzepatide	53	suppressed
Warfarin Sodium	Warfarin Sodium	52	14
Bupropion Xl	Bupropion Hcl	47	11
Metoprolol Tartrate	Metoprolol Tartrate	47	14
Montelukast Sodium	Montelukast Sodium	47	11
Ipratropium Bromide	Ipratropium Bromide	45	17
Pravastatin Sodium	Pravastatin Sodium	45	11
Lorazepam	Lorazepam	44	11
Fenofibrate	Fenofibrate Nanocrystallized	43	suppressed
Synthroid	Levothyroxine Sodium	43	11
Mirtazapine	Mirtazapine	42	11
Fluticasone Propionate	Fluticasone Propionate	40	14
Oxybutynin Chloride Er	Oxybutynin Chloride	40	suppressed
Duloxetine Hcl	Duloxetine Hcl	38	suppressed
Ezetimibe	Ezetimibe	38	suppressed
Finasteride	Finasteride	37	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	14
Valacyclovir	Valacyclovir Hcl	36	13
Xarelto	Rivaroxaban	35	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	34	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Alprazolam	Alprazolam	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Tizanidine Hcl	Tizanidine Hcl	31	suppressed
Lovastatin	Lovastatin	30	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	19
Clopidogrel	Clopidogrel Bisulfate	27	11
Pregabalin	Pregabalin	27	suppressed
Atenolol	Atenolol	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Prednisone	Prednisone	26	15
Midodrine Hcl	Midodrine Hcl	25	suppressed
Valsartan	Valsartan	25	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Spironolactone	Spironolactone	23	suppressed
Diazepam	Diazepam	22	suppressed
Irbesartan	Irbesartan	22	suppressed
Myrbetriq	Mirabegron	22	suppressed
Sildenafil Citrate	Sildenafil Citrate	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Primidone	Primidone	21	suppressed
Temazepam	Temazepam	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	11
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Linzess	Linaclotide	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Spiriva Handihaler	Tiotropium Bromide	18	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Azithromycin	Azithromycin	16	13
Chlorthalidone	Chlorthalidone	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Topiramate	Topiramate	16	suppressed
Amoxicillin	Amoxicillin	15	suppressed
Cilostazol	Cilostazol	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	14	suppressed
Glipizide	Glipizide	13	suppressed
Hydrocortisone	Hydrocortisone	13	11
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Trospium Chloride	Trospium Chloride	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error